Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			5-day change	1st Jan Change
222.26 ^USD	-1.65%		-1.59%	+13.10%

Dec. 11	Certara, Inc. Announces Board Changes	CI
Dec. 11	Certara, Inc. Announces CEO Changes	CI

Analyst Reco.

Morgan Stanley Raises Price Target on IQVIA Holdings to $265 From $250, Keeps Overweight Rating	Dec. 02	MT
Jefferies Adjusts Price Target on IQVIA Holdings to $270 From $255, Maintains Buy Rating	Dec. 02	MT
HSBC Adjusts Price Target on IQVIA Holdings Inc to $270 From $250, Maintains Buy Rating	Dec. 01	MT
BMO Capital Initiates IQVIA Holdings at Outperform With $260 Price Target	Nov. 13	MT
TD Cowen Downgrades IQVIA Holdings to Hold From Buy, Adjusts Price Target to $215 From $206	Nov. 03	MT
Mizuho Securities Adjusts IQVIA Price Target to $250 From $225	Oct. 31	MT
Rothschild & Co Redburn Adjusts IQVIA Holdings Price Target to $254 From $214	Oct. 30	MT
Jefferies Adjusts Price Target on IQVIA Holdings Inc to $255 From $225, Maintains Buy Rating	Oct. 29	MT
JPMorgan Lifts Price Target on IQVIA to $255 From $177, Maintains Overweight Rating	Oct. 29	MT
HSBC Adjusts Price Target on IQVIA Holdings Inc to $250 From $235, Maintains Buy Rating	Oct. 29	MT
UBS Adjusts Price Target on IQVIA to $250 From $225, Maintains Buy Rating	Oct. 29	MT
Truist Raises Price Target on IQVIA Holdings to $265 From $235, Keeps Buy Rating	Oct. 29	MT
Stifel Nicolaus Adjusts IQVIA Price Target to $254 From $234, Maintains Buy Rating	Oct. 29	MT
Evercore ISI Adjusts IQVIA Price Target to $250 From $240, Maintains Outperform Rating	Oct. 29	MT
Citigroup Adjusts IQVIA Price Target to $230 From $200, Maintains Neutral Rating	Oct. 29	MT
Leerink Partners Adjusts IQVIA Price Target to $256 From $232, Maintains Outperform Rating	Oct. 29	MT
Stephens Adjusts IQVIA Price Target to $250 From $220, Maintains Overweight Rating	Oct. 29	MT
Baird Upgrades IQVIA Holdings to Outperform From Neutral, Adjusts Price Target to $258 From $224	Oct. 29	MT
Citigroup Raises Price Target on IQVIA to $230 From $200	Oct. 28	MT
BofA Adjusts Price Target on IQVIA Holdings to $230 From $215	Oct. 20	MT
Deutsche Bank Adjusts Price Target on IQVIA to $235 From $220, Maintains Buy Rating	Oct. 16	MT
Baird Adjusts IQVIA Holdings Price Target to $224 From $206, Maintains Neutral Rating	Oct. 13	MT
IQVIA Shares Higher After HSBC Upgrade	Oct. 09	MT
HSBC Upgrades IQVIA Holdings to Buy From Hold, Adjusts Price Target to $235 From $195	Oct. 09	MT
Analysts recommendations: Datadog, Alphabet, AMD, Elevance Health, Tesla…	Oct. 09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Analyst Reco.

Filters